AstraZeneca says drug helps cut risk of severe COVID
Al Jazeera
Drugmaker says its experimental COVID-19 drug helped cut risk of severe symptoms or death in late-stage study.
Drugmaker AstraZeneca said that its COVID-19 antibodies’ cocktail has helped cut the risk of severe disease or deaths in a late-stage study.
The pharma company announced the results on Monday, marking a boost in its effort to develop coronavirus medicines beyond vaccines.
The drug, a mix of two antibodies called AZD7442, reduced the risk of severe COVID-19 or death by 50 percent in non-hospitalised patients who have had symptoms for seven days or fewer, meeting the main goal of the study.
UN health agency says its decision is ‘based on the rising number and continuing geographic spread of cases.’
In a new interview, the scandal-plagued Gaetz reaffirmed his commitment to being a member of Trump’s ‘America First army’.
Legislators greenlight reforms giving more authority to Daniel Ortega and Rosario Murillo, accused of stifling dissent.
Pep Guardiola leads Man City out for the first time since signing a two-year extension when Tottenham visit on Saturday.
Five healthcare workers killed in Israeli strikes in southern Lebanon, Ministry of Public Health says.
Vulnerable nations are seeking $1.3 trillion annually to deal with the damage caused by climate change and to adapt.
The city’s southern suburbs have been hit repeatedly in recent months
New York judge cancels a sentencing hearing previously scheduled for November 26 without setting a new date.
Many Haitian children face the stark choice of joining a gang or suffering from violence, poverty and hunger engulfing them.
Tapped to lead the Justice Department, Bondi is a former Florida attorney general and longtime Trump supporter.
The arrest warrants against Netanyahu and Gallant could lead to countries rethinking arms deals with Israel, experts say